Advertisement

Topics

Latest "Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer" News Stories

03:50 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer" found in our extensive news archives from over 250 global news sources.

More Information about Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer for you to read. Along with our medical data and news we also list Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer Clinical Trials, which are updated daily. BioPortfolio also has a large database of Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer Companies for you to search.

Showing "Follow Care With Without Assessments Patients Have Undergone" News Articles 1–25 of 30,000+

Monday 25th March 2019

HitGen and Almirall Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration

HitGen Ltd announced that the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest. In this collaboration, HitGen will apply its advanced technology platform, based on DNA-encoded library design, synthesis and screening, to discover novel leads for Almirall. Under the terms of the ag...


Inflazome Receives Funding from The Michael J. Fox Foundation for Parkinson’s Research

Funding in excess of US$1 million to support the development of a brain imaging probe for patient diagnosis and the clinical development of drugs to treat neurodegenerative diseases Inflazome is developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the NLRP3 inflammasome ...

Nurses as Architects

Input from nurses creates a building that supports the needs of clinicians and patients Moving is typically a dreaded chore, but the nursing team at Stamford Health in Stamford, Conn., can’t wait for moving day in September. That’s when they will relocate to a brand-new hospital they helped design. The expansion, consisting of a new […] The post Nurses as Architects appeared firs...


Sunday 24th March 2019

Three-pronged attack can overcome drug resistance in bowel cancer

Combining three targeted drugs together can block drug resistance in bowel cancer patients, a study published in Oncogene has revealed.  Scientists found that bowel cancer cells evolve resistance in response to two molecularly targeted cancer drugs...

Imaging joint cartilage at a molecular level

Australian scientists have reported an advanced imaging technique that allows the condition of joint cartilage to be examined — right down to a molecular level. Described in the journal Scientific Reports, the technique has potential for diagnostics and treatment planning of cartilage disease and impairment, including for osteoarthritis. “Damage and degradation of cartilage around joints lead...

Vital ingredient for blood vessel formation found

Researchers from the University of Virginia (UVA) have discovered an ingredient vital for proper blood vessel formation. Published in the journal Nature Communications, their breakthrough offers a new direction for treating a host of serious conditions — from diabetes to stroke — and explains why other promising treatments have failed. Until now, scientists seeking to grow blood vessels have ...

In Consumers' Self-Care Drive, OTC Firms See Platform For Boosting Industry Trust

Influencing consumers with facts about health care topics frequently littered with inaccurate advice from non-expert social media sources requires having...   

Guidelines Issued on Managing Diabetes in Older Adults

The Endocrine Society has issued guidelines on screening for and treating diabetes in patients aged 65 and older. They were presented on Saturday at the...

Your NEJM Group Today: Afib, Depression & Anxiety / Vitamin K to Reverse Excessive VKA Anticoagulation / Primary Care Opportunities

Here's what we chose for you from NEJM Group today: NEJM Primary Care/Hospitalist Page: Case record: A 62-year-old man with a history...

Opinion: Despite constant criticism and occasional sabotage, the Affordable Care Act has successfully expanded health insurance coverage and controlled runaway health care costs. We need to build on its tremendous cost-control success. https://buff.ly/2Ub

Opinion: Despite constant criticism and occasional sabotage, the Affordable Care Act has successfully expanded health insurance coverage and controlled runaway health care costs. We need to build on its tremendous cost-control success. https://buff.ly/2UbTsSY 

New Dual-Patented SafetyLace® Suicide Prevention Laces by U-Lace to Launch at NatCon19 March 25th and 26th in Nashville, TN.

U-Lace No-Tie Laces widely launches its new dual-patented innovation, SafetyLace® suicide prevention laces, at NatCon19 March 25th and 26th in Nashville, TN. SafetyLace® is a shoelace replacement designed specifically as a suicide prevention safety product for the Behavioral Healthcare industry. ROCHESTER, N.Y. (PRWEB) March 24, 2019 U-Lace No-Tie Sneaker Laces will broadly launch its ...

Quick Take: Accuracy of Unenhanced MRI in the Detection of New Brain Lesions in Multiple Sclerosis

Gadolinium-based contrast material is typically used for follow-up imaging of patients with multiple sclerosis (MS) in order to detect new brain lesions. As magnetic resonance imaging (MRI) techniques have improved in recent years, however, the need for gadolinium-based contrast material in detecting new lesions is now in question. In this retrospective cohort study, investigators analyzed […...

Oral Semaglutide Tops Sitagliptin for Cutting HbA1c, Weight in T2D

(MedPage Today) -- Positive results from PIONEER 3 trial in diabetic patients who aren't responding to metformin with or without sulfonylurea

Teva launches generic iron overload treatment

The EXJADE (deferasirox) tablets are for the treatment of chronic iron overload due to blood transfusions in patients two years of age and older.

Over One-Third T1D Patients Bail on Closed-Loop System

(MedPage Today) -- Trouble staying in automode was primary reason for discontinuation

The Case of the Disappearing Gender Information

(MedPage Today) -- Getting our patients' facts straight in the EHR is crucial

Nipomo Dentist, Dr. Perry Patel, Answers The Question ‘Why Do We Have Wisdom Teeth?’

PASO ROBLES, Calif. (PRWEB) March 24, 2019 Extracting wisdom teeth, those pesky molars that cause pain and swollen jaws, is a very common dental procedure that prompts patients to ask “Why we do have wisdom teeth if they wind up being pulled?” Nipomo dentist, Dr. Perry Patel answers the top...

Why 'Medicare For All' Plays Well In Trump Country

The south and rural areas still lag the rest of the country when it comes to "marketplace insurer competition" under the Affordable Care Act, The Urban Institute reports.

Paso Robles Dentist, Lisa Lu Davis, DMD, Releases a Report About Preventing Toothaches

Few things are more painful than a toothache and a healthy mouth is one of the best ways to prevent tooth pain. Paso Robles dentist, Lisa Lu Davis, has released a report describing the various causes of toothaches and the healthy oral hygiene practices that can help avoid painful conditions. PASO ROBLES, Calif. (PRWEB) March 24, 2019 Few things are more painful than a toothache and a healthy mout...

Week in Review: Tianjin CanSino Staging $160.5 Million Hong Kong IPO

Deals and Financings • Tianjin CanSino Biologics will raise up to $160.5 million in a Hong Kong IPO to develop its 15 vaccine candidates, including an approved Ebola vaccine;• Abbisko Therapeutics of Shanghai completed a $42 million series B fundraising that it will use to start clinical trials of its oncology candidates; • GenoImmune, a BGI subsidiary, raised $18 million in an A fu...

Saturday 23rd March 2019

Patients bear increased financial burden for growth hormone treatment despite FDA approval

(Children's Hospital of Philadelphia) Despite an FDA approval of growth hormone treatment for children with idiopathic short stature (ISS), the mean cost burden to patients and their families has increased over time.

Cost savings from growth hormone insurance strategies not passed on to patients

(The Endocrine Society) Increasingly aggressive insurance strategies have lowered the total costs and insurance costs of growth hormone drugs, but those savings are not being passed on to patients, according to new research to be presented Sunday at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.

Genetic rickets improves more with burosumab than standard care, study finds

(The Endocrine Society) Burosumab, a new injectable medicine to treat X-linked hypophosphatemia (XLH), an inherited form of rickets, demonstrates superior improvements in rickets and other outcomes compared with conventional therapy in an international, phase 3 clinical trial in children. Results from what investigators called the first head-to-head study comparing the new drug with conventional t...

Medicare for All Would Abolish Private Insurance. ‘There’s No Precedent in American History.’

Unlike Obamacare, emerging plans would sweep away the private health insurance system. What would that mean for the companies’ workers, the stock market and the cost of care?

Multifirm Litigation Team Enters into Consent Decree to Settle Decade-Long Battle To Protect Thousands in Colorado With Mental Illness

Colorado criminal defense attorney Iris Eytan and litigation team end longstanding Denver court battle over extensive wait times for court-ordered mental health evaluations. DENVER (PRWEB) March 23, 2019 A longstanding court battle over extensive wait times for court-ordered mental health evaluations has come to a landmark finish thanks to the work of a few dedicated litigators. A coalition of l...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks